2022 Revenues ($USD) : $529,579,388
2022 Revenues (foreign currencies) : JP¥58,169,000,000
2022 R&D spend : n/a
2022 Number of Employees : 5,359
Fiscal Year End : 3/31/2022
Company CEO : Hiroaki Okukubo, president

Dr. Taro Tsuchiya established JMS in the 1960s because he saw the need for disposable medical devices to reduce adverse events related to blood transfusion. Fast forward to today, and the company provides products and services related to infusion/transfusion, infusion/nutrition, dialysis, surgical treatment, and blood/cells. The company says its development process is focused on clinical settings, finding areas that need improvement and sharing insights with healthcare professionals. –CN